USD 140.2 billion
Report ID:
SQMIG35H2027 |
Region:
Global |
Published Date: May, 2025
Pages:
193
|Tables:
136
|Figures:
69
Biomaterials Market size was valued at USD 140.2 billion in 2023 and is poised to grow from USD 161.9 billion in 2024 to USD 512.8 billion by 2032, growing at a CAGR of 15.5% during the forecast period (2025-2032).
Due to factors such as an older demographic, higher incidence rates of heart disease and joint problems, advancing healthcare technologies, and escalating public knowledge about devices that can be implanted in people’s bodies, there is significant growth in the global biomaterials market. This growth can also be attributed to increased government backing for biomaterials research and development along with heightened consumer comprehension regarding the merits associated with products made using biomaterials. Nevertheless, it is foreseen that compatibility challenges and the expensive nature of biomaterial implants could restrain growth of the market.
However, the introduction of new technologies—decellularized dermal matrixes for grafting and hydrogen scaffolding, for example—as well as new products in the fields of neurology, wound healing, and plastic surgery are anticipated to present lucrative growth opportunities for the market over the course of the forecast period. The goal of implantable biomaterials is to reduce the adverse immune response while maintaining proper function, as the body cannot fully integrate any foreign substance to enhance its biological functions. For the purpose of treating neurological, orthopaedic, dental, and cardiovascular disorders, among other medical conditions, these biomaterials interact with biological systems.
Is Rising Demand for Biomaterials in Plastic Surgery and Wound Healing Shaping the Future of the Biomaterials Market?
One of the key trends in the global biomaterials market is the increased demand for biomaterials in plastic surgery and wound healing applications. The biomedical cost of treating injured or diseased organs is rising along with the growing population. Implantable devices are selected due to their proven clinical efficacy, and they are being used as a scaffold for the restoration of soft and hard deformities. Furthermore, they have a number of advantages in wound healing applications. They stimulate tissue development, volume and shape preservation, and wound healing time reduction. Various major players are increasing their product portfolio for plastic surgery and wound healing applications through strategic cooperation and acquisitions. For example, in December 2019, Advanced Medical Solutions (AMS), a surgical and wound care firm, purchased Biomatlante, a surgical biomaterial technology company.
Market snapshot - 2025-2032
Global Market Size
USD 140.2 billion
Largest Segment
Metallic Biomaterials
Fastest Growth
Polymeric Biomaterials
Growth Rate
15.5% CAGR
To get more reports on the above market click here to Buy The Report
The global biomaterials market is segmented on the basis of type, application, and region. Based on the type, the market is segmented into Metallic Biomaterials (Stainless steel, Titanium & titanium alloys, Cobalt-chrome alloys, Silver, Gold, Magnesium, Other metallic biomaterials), Polymeric Biomaterials (Polymethylmethacrylate, Polyethylene, Polyester, Polyvinylchloride, Silicone rubber, Nylon, Polyetherether ketone, Other polymeric biomaterials), Ceramic Biomaterials (Calcium phosphate, Zirconia, Aluminum oxide, Calcium sulfate, Carbon, Glass), Natural Biomaterials (Hyaluronic acid, Collagen, Fibrin, Cellulose, Chitin, Alginates, Gelatin, Chitosan, Silk, Other natural biomaterials). Based on the application, the market is segmented into neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
As per categorization by type, the market is classified as metallic, polymeric, ceramic and natural. Among these, metallic type earned the largest share and continues to dominate the market. The global biomaterials market is dominated by metallic biomaterials, which are widely used in orthopaedic implants, dental applications, and cardiovascular devices. Strength, durability and biocompatibility are the most common features of these materials. Innovations focusing on improving corrosion resistance and biocompatibility drive their sustained dominance in medical applications, where mechanical stability is crucial.
Polymeric biomaterials are the fastest-growing segment in the global biomaterials market, driven by their versatility, light weight, and ease of production. Their versatility allows for extensive application in various medical specialties, and therefore they are the top preference for researchers as well as manufacturers seeking innovative solutions. Their rapid adoprion in tissue engineering, drug delivery, and biodegradable implants has been driven by ongoing improvement in polymer science. The materials have improved performance and bio-compatibility, cementing their position in future medical technologies and driving market growth.
The orthopedic market is the largest segment in the market for biomaterials globally, primarily due to the increased demand for joint replacements, spinal implants, and fracture fixation. As the population ages and the incidence of musculoskeletal disorders increases, the demand for efficient orthopedic solutions also increases. Orthopedic biomaterials provide better strength, biocompatibility, and support for bone regeneration. Such properties have revolutionized the treatment of bone-injury and bone-condition conditions, making orthopedic applications the foremost demand driver in the world biomaterials market.
The cardiovascular segment is emerging as the fastest growing application area in the global biomaterials market. This is attributed to the rising incidence of cardiovascular disease as well as the need for advanced medical devices such as stents, grafts, and pacemakers. Developments in biomaterials have significantly enhanced the biocompatibility and efficacy of cardiovascular implants, reducing complications such as thrombosis and improving patient outcomes. With these materials increasingly used in life-saving procedures, the cardiovascular department is poised to further enjoy rapid growth and play an important role in determining the future of the biomaterials market.
To get detailed analysis on other segments, Request For Free Sample Report
Due to its sophisticated healthcare system, significant R&D spending, and strong concentration of important industry participants, North America leads the global biomaterials market. Large government investment for medical research is beneficial to the region, especially for biomaterials used in orthopedic and cardiovascular applications. In addition, there is a growing need for novel biomaterial-based therapies due to the ageing population and the rise in chronic illness. This industry is being pushed forward through favorable regulatory environments and quick clearance procedures. The North American region's position as a global frontrunner in biomaterial market is also supported by the United States' lead in technological advancements, as well as the use of modern medical equipment.
This part of the world has seen a surge in demand for advanced healthcare materials resulting in an increase in urban centers, enhancement of healthcare facilities and provision of outpaced medical supplies. The surging healthcare costs combined with growing number of aged persons are propelling the growth of orthopedic and cardiovascular biomaterials. Countries such as India and China, for instance have robust manufacturing sectors which have made them better placed than others thus biomaterials availability has risen. In addition, the rise of medical tourism as well as government programs and policies geared towards healthcare innovation have also accelerated market growth. Asia Pacific is expected to grow into a major force in the global biomaterials market as technology usage increases.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Is the Rising Demand for Biomaterials in Wound Healing and Plastic Surgery Shaping the Future of Medical Treatments?
Is the Surge in Musculoskeletal Disorders Fueling Unprecedented Demand for Biomaterial-Based Orthopedic Implants?
Could the Complexity of Orthopedic Disorders Limit the Effectiveness of Biomaterial-Based Solutions?
Could Concerns Over Long-Term Performance and Durability Hinder Biomaterials Market Growth?
Request Free Customization of this report to help us to meet your business objectives.
The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.
Is the Surge in Biodegradable Biomaterials Transforming Modern Medical Applications?
The global biomaterials market is witnessing a significant increase in demand for biodegradable materials due to their growing use in fields like tissue engineering, wound healing, and drug delivery. The materials are gaining popularity because of their biocompatibility and capability to degrade naturally in the body, rendering unnecessary surgical removal and reducing the risk of complications. This rising preference also aligns with the benefits of these materials as far as patient outcomes are concerned. By reducing the need for additional medical procedures, biodegradable biomaterials reduce health care expenditure and enhance recovery periods, thereby becoming a preference option in modern medical applications.
Could Advance Technologies Like Nanotech and 3D Printing Be the Game-Changers in Orthopedic Biomaterials Market Growth?
Nanotechnology and 3D printing have revolutionized orthopedic biomaterials. The technology enables patient-specific implants that closely match individual anatomical structures. With better mechanical property and precise customization, they are achieving improved outcomes and quicker recovery rates for musculoskeletal disorder patients. The technologies are also credited with increased biocompatibility and implant-tissue integration. As a result, the risk of complications is minimized and the long-term outcome is enhanced. The continuous development of these pioneering solutions is not only driving orthopedic treatments ahead but also driving continuous growth in the global biomaterials market.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. SQ identified the key dominating segments of the market by offerings and verticals.
As per SkyQuest analysis, due to factors such as aging population, increasing numbers of individuals with chronic diseases, and developments in medical technology, the global market for biomaterials is sure to expand significantly. However, factors such as dissimilarity and expensiveness are bound to break the momentum of this kind of growth. Despite such difficulties, expansion of the market is expected to be fueled by increasing government funds allocation for R&D and introduction of new tools and treatments in various fields of medicine. The metallic biomaterials segment is having the highest share, and the polymeric biomaterial segment is growing at a quick pace. North America has the highest regional share, and Asia-Pacific is growing quickly. The market is expected to increase with an emphasis on using advanced biomaterials to improve patient outcomes, especially in areas like Asia Pacific where the demand for innovative treatments and healthcare infrastructure is expanding quickly.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 140.2 billion |
Market size value in 2032 | USD 512.8 billion |
Growth Rate | 15.5% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
Recent Developments in Biomaterials Market
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Biomaterials Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biomaterials Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biomaterials Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biomaterials Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Biomaterials Market size was valued at USD 140.2 billion in 2023 and is poised to grow from USD 161.9 billion in 2024 to USD 512.8 billion by 2032, growing at a CAGR of 15.5% during the forecast period (2025-2032).
The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.'BASF SE (Germany)', 'Covestro AG (Germany) ', 'Carpenter Technology Corporation (US) ', 'DSM (Netherlands) ', 'Corbion NV (Netherlands) ', 'Evonik Industries AG (Germany) ', 'Victrex Plc (UK) ', 'CoorsTek Inc. (US) ', 'Berkeley Advanced Biomaterials (US) ', 'CAM Bioceramics B.V. (Netherlands) ', 'GELITA AG (Germany)', 'In July 2024, in developing a new vascular graft based on biomaterials, Medtronic aims at enhancing the long-lasting use of the graft in the case of patients suffering peripheral artery disease. This innovation is evidence to the fact that Medtronic is committed towards creating cardiovascular biomaterials for better patient care and wider range of biomaterials’ products.', 'In May 2024, Zimmer Biomet introduced an innovative orthopaedic implant made from an exclusive, highly porous titanium biomaterial. This advancement further bolsters Zimmer Biomet’s position as a leader in orthopaedic biomaterials while reaffirming its commitment to providing advanced solutions for musculoskeletal health. The purpose of this discovery is to enhance osseointegration and long-term implant stability in joint replacement surgeries.', 'In March 2024, The Stryker Corporation brought forth innovation with a new biodegradable polymer implant for soft tissue healing targeted at sports medicine. The implant serves as a long-lasting therapy for patients by stimulating natural recoveries of their body cells. Such a rationale is in line with Stryker's intentions of diversifying its collection of bio-materials in response to the growing field on sports health.'
Wound healing and plastic surgery are two common applications for biomaterial-based products. Biomaterials are frequently used in plastic surgery to implant, reconstruct, heal, and conceal burns, holes in the body, or soft tissue injuries in a natural and safe manner. One major factor driving the medical industry is the increase in demand for biomaterials in plastic surgery and wound healing.
Due to its sophisticated healthcare system, significant R&D spending, and strong concentration of important industry participants, North America leads the global biomaterials market. Large government investment for medical research is beneficial to the region, especially for biomaterials used in orthopedic and cardiovascular applications. In addition, there is a growing need for novel biomaterial-based therapies due to the ageing population and the rise in chronic illness. This industry is being pushed forward through favorable regulatory environments and quick clearance procedures. The North American region's position as a global frontrunner in biomaterial market is also supported by the United States' lead in technological advancements, as well as the use of modern medical equipment.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2027
[email protected]
USA +1 351-333-4748